Matt Dellatorre

Stock Analyst at Goldman Sachs

(2.62)

# 2,038

Out of 5,245 analysts

5

Total ratings

75%

Success rate

31.7%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic

Stocks Rated by Matt Dellatorre

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TEVA Teva Pharmaceutical Industries	Maintains: Buy	$36 → $45	$34.07	+32.08%	4	Feb 9, 2026
	VTRS Viatris	Initiates: Neutral	$10	$16.65	-39.94%	1	Jun 6, 2025

Teva Pharmaceutical Industries

Feb 9, 2026

Maintains: Buy

Price Target: $36 → $45

Current: $34.07

Upside: +32.08%

Viatris

Jun 6, 2025

Initiates: Neutral

Price Target: $10

Current: $16.65

Upside: -39.94%